Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

Presentation TVT 2022

POINT: The Interaction Between Echo Hemodynamics and Structural Aortic Valve Deterioration

Presenter: Michael J. Reardon

June 09, 2022

Presentation TVT 2022

Acurate Neo2: Update From the ACURATE IDE and Related Studies

Presenter: Michael J. Reardon

June 08, 2022

Presentation TVT 2022

Avoiding PVL by Valve design in the Younger Patients

Presenter: Michael Reardon

June 08, 2022

Presentation TVT 2022

Hemodynamics and the Impact For Younger Patients

Presenter: Michael Reardon

June 08, 2022

Presentation TVT 2022

Evidence of Structural Valve Deterioration After TAVI: Recent Echo Findings

Presenter: Michael J. Reardon

June 08, 2022

Presentation TVT 2019

Illustrative Cases

Presenter: Michael Reardon

June 13, 2019

Presentation TVT 2017

Spotlight Lecture: The SURTAVI LBCT: CoreValve vs Surgery in Intermediate-Risk Aortic Stenosis Patients

Presenter: David J. Cohen, Jeffrey J. Popma, Michael J. Reardon

June 16, 2017

Presentation TVT 2017

The Portico TAVR System: A Cool Case, New Technology, and Clinical Program Updates

Presenter: Martin B. Leon, Michael J. Reardon, Raj Makkar

June 16, 2017

Presentation TVT 2017

The ACURATE TAVR System: A Cool Case, New Technology, and Clinical Program Updates

Presenter: Martin B. Leon, Michael J. Reardon, Thomas Walther

June 16, 2017

Presentation TVT 2017

The LOTUS TAVR System: A Cool Case, New Technology (Including EDGE), and Clinical Program Updates

Presenter: Michael J. Reardon

June 16, 2017

Presentation TVT 2017

The REPRISE III LBCT: A Randomized Trial Comparing LOTUS vs Self-Expanding CoreValve in High-Risk Aortic Stenosis Patients

Presenter: Axel Linke, Jeffrey J. Popma, Michael J. Reardon

June 15, 2017

Presentation TVT 2015

A Surgeons View: Will I Be in the Room in the Future?

Presenter: Susheel K. Kodali, David A. Wood, Michael J. Reardon

June 06, 2015

Presentation TVT 2015

CoreValve US 2-Year Follow-up

Presenter: Michael J. Reardon

June 05, 2015

Presentation TVT 2015

The Importance of Correct Valve Sizing in Surgical and Transcatheter AVR

Presenter: Jonathon A. Leipsic, Jeffrey J. Popma, Michael J. Reardon

June 05, 2015

Presentation TVT 2015

Thoughtful Commentary: Poor Femoral (Alternative) Access and TAVR

Presenter: Neil E. Moat, Allan Schwartz, Michael J. Reardon

June 05, 2015

Presentation TVT 2015

Case Examples and Discussion

Presenter: Ted Feldman, Michael J. Reardon

June 04, 2015

Presentation TVT 2015

Direct Aortic TAVR: Optimal Technique and Complication Management

Presenter: Raj Makkar, Mathew Williams, Michael J. Reardon

June 04, 2015

Presentation TVT 2014

Lessons Learned about Frailty and Comorbidities from the US CoreValve Trials

Presenter: Michael J. Reardon

June 07, 2014

Presentation TVT 2014

Direct Aortic is Clearly Superior to Transapical!

Presenter: Michael J. Reardon

June 07, 2014

Presentation TVT 2014

Direct Aortic TAVR: Indications, Optimal Technique, and Outcomes

Presenter: Michael J. Reardon

June 07, 2014

Advertisement

POINT: The Interaction Between Echo Hemodynamics and Structural Aortic Valve Deterioration

Acurate Neo2: Update From the ACURATE IDE and Related Studies

Avoiding PVL by Valve design in the Younger Patients

Hemodynamics and the Impact For Younger Patients

Evidence of Structural Valve Deterioration After TAVI: Recent Echo Findings

Illustrative Cases

Spotlight Lecture: The SURTAVI LBCT: CoreValve vs Surgery in Intermediate-Risk Aortic Stenosis Patients

The Portico TAVR System: A Cool Case, New Technology, and Clinical Program Updates

The ACURATE TAVR System: A Cool Case, New Technology, and Clinical Program Updates

The LOTUS TAVR System: A Cool Case, New Technology (Including EDGE), and Clinical Program Updates

The REPRISE III LBCT: A Randomized Trial Comparing LOTUS vs Self-Expanding CoreValve in High-Risk Aortic Stenosis Patients

A Surgeons View: Will I Be in the Room in the Future?

CoreValve US 2-Year Follow-up

The Importance of Correct Valve Sizing in Surgical and Transcatheter AVR

Thoughtful Commentary: Poor Femoral (Alternative) Access and TAVR

Case Examples and Discussion

Direct Aortic TAVR: Optimal Technique and Complication Management

Lessons Learned about Frailty and Comorbidities from the US CoreValve Trials

Direct Aortic is Clearly Superior to Transapical!

Direct Aortic TAVR: Indications, Optimal Technique, and Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content